Emerging Topics in Modeling Interval-Censored Survival Data

- Part I Introduction and Review. - Overview of Historical Developments in Modeling Interval-Censored Survival Data. - Overview of Recent Advances on the Analysis of Interval-Censored Failure Time Data. - Predictive Accuracy of Prediction Model for Interval-Censored Data. - Part II Emerging Topics in Methodology. - A Practical Guide to Exact Confidence Intervals for a Distribution of Current Status Data Using the Binomial Approach. - Accelerated Hazards Model and Its Extensions for Interval-Censored Data. - Maximum Likelihood Estimation of Semiparametric Regression Models with Interval-Censored Data. - Use of the INLA Approach for the Analysis of Interval-Censored Data. - Copula Models and Diagnostics for Multivariate Interval-Censored Data. - Efficient Estimation of the Additive Risks Model for Interval-Censored Data. - Part III Emerging Topics in Applications. - Modeling and Analysis of Chronic Disease Processes Under Intermittent Observation. - Case-Cohort Studies with Time-Dependent Covariates and Interval-Censored Outcome. - The BivarIntCensored: An R Package for Nonparametric Inference of Bivariate Interval-Censored Data. - Joint Modeling for Longitudinal and Interval-Censored Survival Data: Application to IMPI Multi-Center HIV/AIDS Clinical Trial. - Regression Analysis with Interval-Censored Covariates. Application to Liquid Chromatography. - Misclassification Simulation Extrapolation Procedure for Interval-Censored Log-Logistic Accelerated Failure Time Model.

Professor (Tony) Jianguo Sun is a Curators' Distinguished Professor in the Department of Statistics at the University of Missouri, USA.  He is a world-leading researcher in survival data analysis and has in particular been working on the analysis of interval-censored data for over 30 years.   He has published over 200 papers and three books and has been invited several times to write review articles on the analysis of interval-censored data.  Professor Sun is a Fellow of the American Statistical Association and the Institute of Mathematical Statistics and an Elected Member of the International Statistical Institute.

Professor (Din) Ding-Geng Chen received his Ph.D. in Statistics from the University of Guelph (Canada) in 1995 and is now executive director and professor in Biostatistics at the College of Health Solutions, Arizona State University. He served as a professor in biostatistics at the University of North Carolina-Chapel Hill, a biostatistics professor at the University of Rochester Medical Center, and held the Karl E. Peace endowed eminent scholar chair in biostatistics at the Jiann-Ping Hsu College of Public Health at Georgia Southern University. Dr. Chen is an elected fellow of the American Statistical Association and a senior expert consultant for biopharmaceuticals and government agencies with extensive expertise in clinical trial biostatistics. He has more than 200 scientific publications and has co-authored/co-edited 33 books on clinical trials, survival data, meta-analysis, Monte-Carlo simulation-based statistical modeling, causal inference, big data analytics, and statistical modeling for public health applications. His research has been funded as PI/Co-PI from NIH R01s and other multi-milliondollar state and federal government agencies.